Parkinson’s Disease and Alzheimer’s Disease Dimensional Neuroimaging Initiative in Japan

Takashi Hanakawa¹⁾²⁾

¹⁾Integrated Neuroanatomy and Neuroimaging, Kyoto University Graduate School of Medicine
²⁾Advanced Neuroimaging, Integrative Brain Imaging Center, National Center of Neurology and Psychiatry

The Japan Parkinson’s Disease and Alzheimer’s Disease Dimensional Neuroimaging Initiative （PADNI） is a 5-year multi-center cohort study launched in 2019.　PADNI intends to collect clinical, biological and neuroimaging data to help understand the pathophysiology of cognitive disturbance in Alzheimer’s disease spectrum and Parkinson’s disease spectrum in a comprehensive manner.　In particular, PADNI employs a harmonized magnetic resonance imaging protocol （HARP） consistent with the Human Connectome Project to gain insight into the circuit pathophysiology of dementia syndrome bridging over Alzheimer’s disease and Parkinson’s disease.

Address correspondence to Dr. Takashi Hanakawa, Integrated Neuroanatomy and Neuroimaging, Kyoto University Graduate School of Medicine（Yoshida-Konoe-cho, Sakyo-ku, Kyoto, Kyoto 606-8501, Japan）